LegoChem Biosciences financials at a glance

+ Portfolio

The revenue of LegoChem Biosciences is reported as 35.5 billion Won in the fiscal year 2023. The earnings were -1792 Won per share in 2023, which was 90.21 lower than 2021. And about -63.66667 billion Won are reported as free cash flow in the financials of LegoChem Biosciences 2023. No dividends were paid to the shareholders of the LegoChem Biosciences stock KOSDAQ:A141080 in the financial year 2023.

₩33.41B

Revenue

₩-1,845.00

Earnings Per Share

53.42%

Gross Margin %

₩-18,700.00M

Free Cash Flow

Revenue

33,412.04

Earnings Per Share

-1,845.00

Gross Margin %

53.42

Free Cash Flow

-18,700.00

Financials

Year	Year	TTM	2022	2021	2020	2015
Rev.	Revenue	N/A	₩33.41B	₩32.16B	₩49.39B	₩11.00B
GM %	Gross Margin %	52.66%	53.42%	55.03%	0.00%	61.37%
OM	Operating Margin	-,232.98%	-,150.77%	-86.16%	0.00%	0.00%
EPS	Earnings Per Share	₩-3,199.09	₩-1,845.00	₩-,970.00	₩-,307.00	₩-,343.39
Div.	Dividends	N/A	₩0.00	₩0.00	₩0.00	₩0.00
PR %	Payout Ratio %	0	0	0	0	0
Sha.	Shares	N/AM	25.5M	24.23M	23.68M	18.09M
OCF	Operating Cash Flow	N/A	₩3.10B	₩-42,048.76M	₩-14,893.36M	₩-8,780.26M
FCF	Free Cash Flow	N/A	₩-18,700.00M	₩-60,357.74M	₩-17,632.83M	₩-9,145.27M
FCFS	Free Cash Flow Per Share	₩-2,000.18	₩-,488.76	₩-2,507.47	₩0.00	₩-,592.30

LegoChem Biosciences financials at a glance

Financials

Discover